We began our tumor studies by assessing the expression of CCR2 and MCP-1/CCL2 within tumors that developed in syngeneic C57BL/6 mice after subcutaneous injection of a murine lung adenocarcinoma cell line, TC1. This evidence concerns the gene CCL2 and neoplasm.